<code id='3F01DB745D'></code><style id='3F01DB745D'></style>
    • <acronym id='3F01DB745D'></acronym>
      <center id='3F01DB745D'><center id='3F01DB745D'><tfoot id='3F01DB745D'></tfoot></center><abbr id='3F01DB745D'><dir id='3F01DB745D'><tfoot id='3F01DB745D'></tfoot><noframes id='3F01DB745D'>

    • <optgroup id='3F01DB745D'><strike id='3F01DB745D'><sup id='3F01DB745D'></sup></strike><code id='3F01DB745D'></code></optgroup>
        1. <b id='3F01DB745D'><label id='3F01DB745D'><select id='3F01DB745D'><dt id='3F01DB745D'><span id='3F01DB745D'></span></dt></select></label></b><u id='3F01DB745D'></u>
          <i id='3F01DB745D'><strike id='3F01DB745D'><tt id='3F01DB745D'><pre id='3F01DB745D'></pre></tt></strike></i>

          entertainment

          entertainment

          author:Wikipedia    Page View:89547
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Why you shouldn’t ask, “What country has the best health care?”
          Why you shouldn’t ask, “What country has the best health care?”

          AdobeI’vespentmycareerstudyinghowdifferenthealthcaresystemswork.Peoplelovetoaskmewhichcountryhastheb

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Medicare drug price negotiation legal challenge met with skepticism

          AdobeWILMINGTON,Del.—Wednesdaywasthefirsttimethatafederaljudgeaskedquestionsin-personofdrugindustryl